These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


246 related items for PubMed ID: 19437524

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Chaperone activity of bicyclic nojirimycin analogues for Gaucher mutations in comparison with N-(n-nonyl)deoxynojirimycin.
    Luan Z, Higaki K, Aguilar-Moncayo M, Ninomiya H, Ohno K, García-Moreno MI, Ortiz Mellet C, García Fernández JM, Suzuki Y.
    Chembiochem; 2009 Nov 23; 10(17):2780-92. PubMed ID: 19830760
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Convergent approach toward the synthesis of the stereoisomers of C-6 homologues of 1-deoxynojirimycin and their analogues: evaluation as specific glycosidase inhibitors.
    Pandey G, Dumbre SG, Khan MI, Shabab M.
    J Org Chem; 2006 Oct 27; 71(22):8481-8. PubMed ID: 17064023
    [Abstract] [Full Text] [Related]

  • 5. Fluorescent-tagged sp2-iminosugars with potent β-glucosidase inhibitory activity.
    Aguilar-Moncayo M, García-Moreno MI, Stütz AE, García Fernández JM, Wrodnigg TM, Ortiz Mellet C.
    Bioorg Med Chem; 2010 Nov 01; 18(21):7439-45. PubMed ID: 20889348
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Synthesis and evaluation of glycosidase inhibitory activity of N-butyl 1-deoxy-D-gluco-homonojirimycin and N-butyl 1-deoxy-L-ido-homonojirimycin.
    Markad SD, Karanjule NS, Sharma T, Sabharwal SG, Dhavale DD.
    Bioorg Med Chem; 2006 Aug 15; 14(16):5535-9. PubMed ID: 16682208
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Design and synthesis of highly potent and selective pharmacological chaperones for the treatment of Gaucher's disease.
    Compain P, Martin OR, Boucheron C, Godin G, Yu L, Ikeda K, Asano N.
    Chembiochem; 2006 Sep 15; 7(9):1356-9. PubMed ID: 16871601
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Iminosugar glycosidase inhibitors: structural and thermodynamic dissection of the binding of isofagomine and 1-deoxynojirimycin to beta-glucosidases.
    Zechel DL, Boraston AB, Gloster T, Boraston CM, Macdonald JM, Tilbrook DM, Stick RV, Davies GJ.
    J Am Chem Soc; 2003 Nov 26; 125(47):14313-23. PubMed ID: 14624580
    [Abstract] [Full Text] [Related]

  • 13. Bicyclic (galacto)nojirimycin analogues as glycosidase inhibitors: effect of structural modifications in their pharmacological chaperone potential towards β-glucocerebrosidase.
    Aguilar-Moncayo M, García-Moreno MI, Trapero A, Egido-Gabás M, Llebaria A, Fernández JM, Mellet CO.
    Org Biomol Chem; 2011 May 21; 9(10):3698-713. PubMed ID: 21451818
    [Abstract] [Full Text] [Related]

  • 14. Biological properties of D- and L-1-deoxyazasugars.
    Kato A, Kato N, Kano E, Adachi I, Ikeda K, Yu L, Okamoto T, Banba Y, Ouchi H, Takahata H, Asano N.
    J Med Chem; 2005 Mar 24; 48(6):2036-44. PubMed ID: 15771446
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Synthesis and NMR experiments of (4,5,6-13C)-deoxymannojirimycin. A new entry to 13C-labeled glycosidase inhibitors.
    Murruzzu C, Alonso M, Canales A, Jiménez-Barbero J, Riera A.
    Carbohydr Res; 2007 Sep 03; 342(12-13):1805-12. PubMed ID: 17511974
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 13.